[HTML][HTML] Forty years of IVF
C Niederberger, A Pellicer, J Cohen, DK Gardner… - Fertility and sterility, 2018 - Elsevier
This monograph, written by the pioneers of IVF and reproductive medicine, celebrates the
history, achievements, and medical advancements made over the last 40 years in this …
history, achievements, and medical advancements made over the last 40 years in this …
The role of anti-Müllerian hormone (AMH) in ovarian disease and infertility
J Bedenk, E Vrtačnik-Bokal, I Virant-Klun - Journal of assisted reproduction …, 2020 - Springer
Purpose In this review, the current knowledge on anti-Müllerian hormone (AMH) is
presented, concerning its value in disease and IVF treatment as well as in terms of its …
presented, concerning its value in disease and IVF treatment as well as in terms of its …
[HTML][HTML] The novel POSEIDON stratification of 'Low prognosis patients in Assisted Reproductive Technology'and its proposed marker of successful outcome
In reproductive medicine little progress has been achieved regarding the clinical
management of patients with a reduced ovarian reserve or poor ovarian response (POR) to …
management of patients with a reduced ovarian reserve or poor ovarian response (POR) to …
Interventions to prevent or reduce the incidence and severity of ovarian hyperstimulation syndrome: a systematic umbrella review of the best clinical evidence
Ovarian hyperstimulation syndrome (OHSS) is a potentially life-threating iatrogenic
complication of the early luteal phase and/or early pregnancy after in vitro fertilization (IVF) …
complication of the early luteal phase and/or early pregnancy after in vitro fertilization (IVF) …
The development of gonadotropins for clinical use in the treatment of infertility
B Lunenfeld, W Bilger, S Longobardi, V Alam… - Frontiers in …, 2019 - frontiersin.org
The first commercially available gonadotropin product was a human chorionic gonadotropin
(hCG) extract, followed by animal pituitary gonadotropin extracts. These extracts were …
(hCG) extract, followed by animal pituitary gonadotropin extracts. These extracts were …
Using serum anti-Müllerian hormone levels to predict the chance of live birth after spontaneous or assisted conception: a systematic review and meta-analysis
M Peigné, V Bernard, L Dijols, H Creux… - Human …, 2023 - academic.oup.com
STUDY QUESTION Is serum anti-Müllerian hormone (AMH) level predictive of cumulative
live birth (CLB) rate after ART or in women trying to conceive naturally? SUMMARY …
live birth (CLB) rate after ART or in women trying to conceive naturally? SUMMARY …
Anti Müllerian hormone: more than a biomarker of female reproductive function
M Victoria, J Labrosse, F Krief, I Cédrin-Durnerin… - Journal of gynecology …, 2019 - Elsevier
Anti-Müllerian hormone (AMH), known for its role during sexual differentiation, is a dimeric
glycoprotein that belongs to the transforming growth factor-β (TGF-β) family. AMH has …
glycoprotein that belongs to the transforming growth factor-β (TGF-β) family. AMH has …
Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 2: The predicted hyper responder
SC Oudshoorn, TC Van Tilborg… - Human …, 2017 - academic.oup.com
STUDY QUESTION Does a reduced FSH dose in women with a predicted hyper response,
apparent from a high antral follicle count (AFC), who are scheduled for IVF/ICSI lead to a …
apparent from a high antral follicle count (AFC), who are scheduled for IVF/ICSI lead to a …
Prevention and management of ovarian hyperstimulation syndrome
SM Nelson - Thrombosis research, 2017 - Elsevier
Ovarian hyperstimulation syndrome (OHSS) is a serious iatrogenic complication of ovarian
stimulation. It is feasible to identify patients at risk, modify stimulation strategies to ameliorate …
stimulation. It is feasible to identify patients at risk, modify stimulation strategies to ameliorate …
A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF/ICSI patients
STUDY QUESTION Is ovarian stimulation with follitropin delta in its individualised fixed-dose
regimen at least as efficacious as follitropin alfa in a conventional dosing regimen in Asian …
regimen at least as efficacious as follitropin alfa in a conventional dosing regimen in Asian …